10x基因组学
TXG
69.86
-2.53
-3.50%
10x基因组学
US · TXG
#1311 按市值排名
上市于 2019
69.86
-2.53
-3.50%
实时 - 追踪5344个代码 - 心跳于206秒前
· 2026-10-16 20:02
✦ 量化股权信号 计算方式说明
增持
- 机构持股总比例上升了7.2个百分点。
机构持股
- 机构持股比例
- 104.18% +7.24pp
- 机构数量
- 459
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向分歧机构在上一报告期增持了股份,同时该股在最近20个交易日的主力资金呈净流出——两者方向出现分歧。
机构持股变动数据按季度发布且存在滞后;资金流向数据为每日更新。请将其作为方向性的交叉验证参考,而非精确的择时信号。
持股人类型
Mutual Fund85.55%
Hedge Fund9.67%
Individual/Insider7.79%
Public Company4.19%
VC/PE Fund1.37%
Private Company1.33%
Government Pension Fund0.76%
Family Office/Trust0.69%
Insurance Company0.40%
主要股东 截至 2026-06-30
FMR
14.22% · 18.52M 股
T. Rowe Price Group, Inc.
11.75% · 15.31M 股
BlackRock
8.29% · 10.80M 股
ARK Investment Management LLC
7.68% · 10.00M 股
Vanguard Portfolio Management, LLC
5.36% · 6.98M 股
Vanguard Capital Management, LLC
4.54% · 5.92M 股
Quantinno Capital Management LP
4.21% · 5.48M 股
Amova Asset Management
3.22% · 4.19M 股
Serge Saxonov
3.16% · 4.11M 股
Benjamin Hindson
2.55% · 3.32M 股
条形长度是相对于此处列出的最大股东而言,并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 13次买入 · 37次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Serge Saxonov | Chief Executive Officer | 3.16% |
| Benjamin Hindson | Co-Founder, President, Chief Scientific Officer & Director | 2.55% |
| John Stuelpnagel | Independent Chairperson | 1.86% |
| Adam Taich | CFO, Treasurer, Principal Financial Officer & Principal Accounting Officer | 0.08% |
| Alan Mateo | Director | 0.05% |
| Sridhar Kosaraju | Independent Director | 0.05% |
| Kimberly Popovits | Independent Director | 0.02% |
| Shehnaaz Suliman | Independent Director | 0.01% |
| Sarah Teichmann | -- | 0.01% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-21 | Shehnaaz Suliman | Independent Director | Automatic Disposition | -5,723 | $78.20–82.28 |
| 2026-09-21 | Serge Saxonov | Chief Executive Officer | Automatic Disposition | -25,000 | $78.23–82.37 |
| 2026-09-08 | Adam Taich | CFO, Treasurer, Principal Financial Officer & Principal Accounting Officer | Automatic Disposition | -46,388 | $63.68–65.26 |
| 2026-09-02 | John Stuelpnagel | Independent Chairperson | Open Market Disposition | -20,000 | $60.66–62.61 |
| 2026-08-31 | Serge Saxonov | Chief Executive Officer | Other Disposition | -100 | -- |
| 2026-08-25 | Serge Saxonov | Chief Executive Officer | Automatic Disposition | -10,486 | $63.02–64.75 |
| 2026-08-23 | Shehnaaz Suliman | Independent Director | Automatic Disposition | -2,207 | $62.73–63.97 |
| 2026-08-23 | Adam Taich | CFO, Treasurer, Principal Financial Officer & Principal Accounting Officer | Open Market Disposition | -17,166 | $63.02 |
| 2026-08-23 | Serge Saxonov | Chief Executive Officer | Open Market Disposition | -18,545 | $63.02 |
| 2026-08-23 | Benjamin Hindson | Co-Founder, President, Chief Scientific Officer & Director | Open Market Disposition | -13,818 | $63.02 |
| 2026-08-19 | Serge Saxonov | Chief Executive Officer | Other Disposition | -4,000 | -- |
| 2026-08-13 | Sarah Teichmann | -- | Automatic Disposition | -7,551 | $57.15–57.29 |
| 2026-08-13 | Sarah Teichmann | -- | Intent to Sell (Form 144) | -2,273 | $57.15 |
| 2026-08-12 | Sarah Teichmann | -- | Intent to Sell (Form 144) | -5,278 | $57.29 |
| 2026-08-10 | John Stuelpnagel | Independent Chairperson | Open Market Disposition | -20,000 | $57.58–58.73 |
| 2026-06-21 | Serge Saxonov | Chief Executive Officer | Automatic Disposition | -30,000 | $33.29–36.16 |
| 2026-06-15 | Shehnaaz Suliman | Independent Director | Automatic Disposition | -5,723 | $32.59–33.27 |
| 2026-06-03 | Kimberly Popovits | Independent Director | Other Acquisition | +8,829 | -- |
| 2026-06-03 | John Stuelpnagel | Independent Chairperson | Other Acquisition | +8,829 | -- |
| 2026-06-03 | Shehnaaz Suliman | Independent Director | Other Acquisition | +8,829 | -- |
Form 4 申报记录,每家公司显示最新的一批。"Other Derivative Acquisition"(其他衍生品获取)类目多为限制性股票/期权归属,并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 20:02:29 · 仅供参考,不构成投资建议,也未考虑您的具体情况。
10x基因组学 讨论区 0 条评论